In a new study published in The Journal of Viral Hepatitis, researcher Hee-Soon Juon, MSN, PhD explores how stigma against HBV affects those with the condition.
In a new paper, published in EMBO Reports, a team including Davide Trotti, PhD, a neuroscientist at Thomas Jefferson University, showed how altered glucose metabolism in the brain and spinal cord are damaging to motor neurons in preclinical models that carry the genetic C9-NRE mutation.
Molecular biologist Yohei Kirino, PhD and his research team at Thomas Jefferson University has found that certain RNA molecules in people with tuberculosis are drastically different than those in healthy people.
Today, Jefferson and Lehigh Valley Health Network (LVHN) announced the close of the transaction making them one health system. The combination creates a leading integrated academic health care delivery system, alongside a national doctoral research university and an expanded not-for-profit health plan.
Jonas Philanthropies, a leading supporter of doctoral nursing education in the U.S., and the American Association of Colleges of Nursing (AACN), announced that Jacquelyn O'Rourke-Fulford, a Doctor of Nursing Practice (DNP) student at Thomas Jefferson University’s College of Nursing, has been selected as a Jonas Scholar for the program’s 2024-2026 cohort.
A recent study led by Preeti Zanwar, PhD, MPH, MS, an adjunct research and teaching faculty and aging and health disparities researcher at Jefferson, sheds light on the prevalence of multimorbidity among aging adults in India and recommends how public health officials can prevent adverse effects.
In a recent study, Scott A. Waldman, MD, PhD, and his team discovered that a gut receptor protein called GUCY2C could prevent PD development by protecting against brain damage and toxic insult.
“Recessive Dystrophic Epidermolysis Bullosa (RDEB) is the worst disease you’ve probably never heard of,” says dermatology researcher, Andrew South, PhD. RDEB patients and their families know just how horrible it can be.
Sidney Kimmel Medical College student Joel Sacris has been selected for medical rotation with the New York Jets as part of the NFL Diversity in Sports Medicine Pipeline Initiative.
In a new study in the American Journal of Preventive Medicine examining how patterns of prenatal substance use impact attention-deficit/hyperactivity disorder (ADHD) diagnoses in children, researchers found that co-use of alcohol and tobacco, and use of cannabis alone, posed the greatest risk.
In a recent study, Jefferson researcher and first author Wookjin Choi, PhD, developed an artificial-intelligence algorithm that could re-analyze these PET/CT images and accurately predict patients with more inflammation in the heart – often a precursor of long-term damage.
Neuroscientist Manuel Covarrubias, MD, PhD and his research assistant Qiansheng Liang, MD led a study published in Nature Communications that focused on Kv3 channels, the subclass of voltage-gated potassium channels that selectively bind AUT5.
A new study with senior author Marja Nevalainen, MD, PhD, a translational medicine physician-scientist, suggests that a clever trick of cell signaling may curbs tumor growth through a different route.
Using the creative problem-solving framework of design thinking, Drs. Rios-Vega, Fields and Schaaf analyzed healthcare environments and met with parents of autistic children, healthcare professionals and designers to collaboratively brainstorm how the experience could be improved.
A new study led by Thomas Jefferson University researchers has found that American currency carries much more than germs on its surface.
